SE463074B - Anvaendning av aromatashaemmare och antiandrogener foer framstaellning av laekemedel foer profylax och terapi av benign prostatahyperplasi - Google Patents
Anvaendning av aromatashaemmare och antiandrogener foer framstaellning av laekemedel foer profylax och terapi av benign prostatahyperplasiInfo
- Publication number
- SE463074B SE463074B SE8104624A SE8104624A SE463074B SE 463074 B SE463074 B SE 463074B SE 8104624 A SE8104624 A SE 8104624A SE 8104624 A SE8104624 A SE 8104624A SE 463074 B SE463074 B SE 463074B
- Authority
- SE
- Sweden
- Prior art keywords
- manufacture
- antiandrogen
- aromatase inhibitor
- testolactone
- carbon atoms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19813121152 DE3121152A1 (de) | 1981-05-22 | 1981-05-22 | "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie" |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8104624L SE8104624L (sv) | 1982-11-23 |
SE463074B true SE463074B (sv) | 1990-10-08 |
Family
ID=6133382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8104624A SE463074B (sv) | 1981-05-22 | 1981-07-31 | Anvaendning av aromatashaemmare och antiandrogener foer framstaellning av laekemedel foer profylax och terapi av benign prostatahyperplasi |
Country Status (15)
Country | Link |
---|---|
US (1) | US4598072A (de) |
JP (1) | JPS57193412A (de) |
AU (1) | AU563785B2 (de) |
BE (1) | BE890522A (de) |
CA (1) | CA1186998A (de) |
CH (1) | CH648211A5 (de) |
DE (1) | DE3121152A1 (de) |
DK (1) | DK354881A (de) |
FR (1) | FR2506158B1 (de) |
GB (1) | GB2102287B (de) |
IT (1) | IT1139175B (de) |
LU (1) | LU83545A1 (de) |
NL (1) | NL8103875A (de) |
SE (1) | SE463074B (de) |
ZA (1) | ZA823501B (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3607651A1 (de) * | 1986-03-06 | 1987-09-10 | Schering Ag | Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer |
US4895715A (en) * | 1988-04-14 | 1990-01-23 | Schering Corporation | Method of treating gynecomastia |
US5364847A (en) * | 1989-03-10 | 1994-11-15 | Endorecherche | Inhibitors of sex steroid biosynthesis and methods for their production and use |
US5372996A (en) * | 1989-03-10 | 1994-12-13 | Endorecherche, Inc. | Method of treatment of androgen-related diseases |
US5595985A (en) | 1989-03-10 | 1997-01-21 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
WO1991000733A1 (en) * | 1989-07-07 | 1991-01-24 | Endorecherche Inc. | Method of treatment of androgen-related diseases |
JP3332377B2 (ja) * | 1989-07-07 | 2002-10-07 | アンドルシェルシュ・インコーポレイテッド | 良性前立腺過形成の予防および/または治療のための組合せ療法 |
DE4001060A1 (de) * | 1990-01-16 | 1991-07-18 | Kanoldt Arzneimittel Gmbh | Verwendung einer ungesaettigten fettsaeure oder ihrer derivate in der human- und veterinaermedizin und zur herstellung einer arzneimittelzubereitung |
CZ286894A3 (en) * | 1992-05-21 | 1995-09-13 | Endorecherche Inc | Pharmaceutical preparation |
GB2278054A (en) * | 1993-05-18 | 1994-11-23 | Zeneca Ltd | Compounds for the treatment of urinary incontinence |
WO1999046279A2 (en) | 1998-03-11 | 1999-09-16 | Endorecherche, Inc. | INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
DE19825591A1 (de) * | 1998-06-09 | 1999-12-23 | Jenapharm Gmbh | Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata |
GB9930839D0 (en) * | 1999-12-30 | 2000-02-16 | Pharmacia & Upjohn Spa | Process for treating gynecomastia |
GB0012293D0 (en) * | 2000-05-23 | 2000-07-12 | Astrazeneca Ab | Pharmaceutical combination |
US20040077605A1 (en) * | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US7001911B2 (en) * | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
EP1299094A2 (de) * | 2000-06-28 | 2003-04-09 | Bristol-Myers Squibb Company | Selektive androgenrezeptormodulatoren und methoden zu deren identifizierung, entwurf und verwendung |
WO2002002112A1 (en) * | 2000-07-05 | 2002-01-10 | Astrazeneca Ab | Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition |
WO2002002113A1 (en) * | 2000-07-05 | 2002-01-10 | Astrazeneca Ab | Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition |
GB0016426D0 (en) * | 2000-07-05 | 2000-08-23 | Astrazeneca Ab | Pharmaceutical combination |
US6953679B2 (en) | 2000-09-19 | 2005-10-11 | Bristol-Myers Squibb Company | Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof |
EP1854798A3 (de) * | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion |
US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US6607755B2 (en) * | 2001-06-21 | 2003-08-19 | Michael Donald Farley | Anti-aromatase pharmaceutical composition for controlling testosterone/estrone ratios |
SE0103839D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Pharmaceutical formulation & product |
WO2003053358A2 (en) * | 2001-12-19 | 2003-07-03 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
WO2004058234A2 (en) | 2002-12-27 | 2004-07-15 | Schering Aktiengesellschaft | Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors |
DK2500062T3 (en) * | 2007-11-13 | 2015-09-21 | Curadis Gmbh | C-19 steroids to specific therapeutic applications, |
EP2387401A1 (de) * | 2009-01-14 | 2011-11-23 | Boehringer Ingelheim International GmbH | Verfahren zur behandlung von kolorektalkarzinom |
PT2965759T (pt) | 2012-02-06 | 2020-02-07 | Innovative Med Concepts Llc | Composto antiviral e inibidor e terapia de combinação do inibidor de cox-2 para fibromialgia |
EP2762135A1 (de) * | 2013-02-04 | 2014-08-06 | Sanofi | Verfahren zur Verringerung des Risikos auf einer schädlichen Teriflunomid- und Rosuvastatininteraktion bei Patienten mit Multipler Sklerose |
EP3129015B1 (de) * | 2014-04-08 | 2021-07-14 | The Methodist Hospital | Inos-hemmende zusammensetzungen und deren verwendung als brustkrebs-therapeutika |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3423507A (en) * | 1966-02-25 | 1969-01-21 | Schering Corp | Method of treating benign prostratic hypertrophy |
US3449494A (en) * | 1966-09-29 | 1969-06-10 | Squibb & Sons Inc | Anti-inflammatory compositions containing a corticoidal steroid and a testololactone |
US4055641A (en) * | 1976-05-10 | 1977-10-25 | Richardson-Merrell Inc. | Method of treating benign prostatic hypertrophy |
DE2817157A1 (de) * | 1978-04-17 | 1979-10-25 | Schering Ag | Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie |
US4235893A (en) * | 1978-05-08 | 1980-11-25 | Brodie Angela M | Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis |
EP0100566B1 (de) * | 1982-07-14 | 1986-02-19 | Akzo N.V. | 19-Thioandrostan-Derivate |
-
1981
- 1981-05-22 DE DE19813121152 patent/DE3121152A1/de active Granted
- 1981-07-31 SE SE8104624A patent/SE463074B/sv not_active IP Right Cessation
- 1981-08-10 CH CH5141/81A patent/CH648211A5/de not_active IP Right Cessation
- 1981-08-10 DK DK354881A patent/DK354881A/da not_active Application Discontinuation
- 1981-08-11 LU LU83545A patent/LU83545A1/de unknown
- 1981-08-17 JP JP56127857A patent/JPS57193412A/ja active Granted
- 1981-08-19 NL NL8103875A patent/NL8103875A/nl not_active Application Discontinuation
- 1981-08-28 CA CA000384827A patent/CA1186998A/en not_active Expired
- 1981-09-16 IT IT23988/81A patent/IT1139175B/it active
- 1981-09-28 BE BE0/206085A patent/BE890522A/fr not_active IP Right Cessation
- 1981-10-26 FR FR8120022A patent/FR2506158B1/fr not_active Expired
-
1982
- 1982-05-10 GB GB08213407A patent/GB2102287B/en not_active Expired
- 1982-05-19 ZA ZA823501A patent/ZA823501B/xx unknown
- 1982-05-24 AU AU84075/82A patent/AU563785B2/en not_active Ceased
- 1982-12-10 US US06/448,673 patent/US4598072A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK354881A (da) | 1982-11-23 |
IT8123988A0 (it) | 1981-09-16 |
AU8407582A (en) | 1982-11-25 |
US4598072A (en) | 1986-07-01 |
IT1139175B (it) | 1986-09-24 |
GB2102287A (en) | 1983-02-02 |
BE890522A (fr) | 1982-03-29 |
FR2506158A1 (fr) | 1982-11-26 |
JPS57193412A (en) | 1982-11-27 |
DE3121152C2 (de) | 1991-02-07 |
CA1186998A (en) | 1985-05-14 |
JPH0150207B2 (de) | 1989-10-27 |
CH648211A5 (de) | 1985-03-15 |
LU83545A1 (de) | 1981-12-01 |
NL8103875A (nl) | 1982-12-16 |
DE3121152A1 (de) | 1982-12-09 |
AU563785B2 (en) | 1987-07-23 |
FR2506158B1 (fr) | 1986-05-09 |
ZA823501B (en) | 1983-03-30 |
GB2102287B (en) | 1985-02-27 |
SE8104624L (sv) | 1982-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE463074B (sv) | Anvaendning av aromatashaemmare och antiandrogener foer framstaellning av laekemedel foer profylax och terapi av benign prostatahyperplasi | |
JP6740497B2 (ja) | 癌を治療するための方法及び組成物 | |
US5763433A (en) | Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof | |
AU643445B2 (en) | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia | |
US6423698B1 (en) | Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia | |
US4596797A (en) | Use of aromatase-inhibitors for prophylaxis and/or treatment of benign prostatic hyperplasia | |
JP2002541126A (ja) | 低用量エストロゲン断続的ホルモン補充療法 | |
JPS62500451A (ja) | ホルモン依存性がんの併用治療のための医薬組成物 | |
EP1854465A1 (de) | Verwendung von 4,17 beta-dihydroxyandrost-4-ene-3-one zur Behandlung von Krebs | |
EP1372664A1 (de) | Verwendung von steroiden für die behandlung von blutzellenmangel | |
JP5278313B2 (ja) | 輸送体増強コルチコステロイド活性 | |
EP0155934A1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Störungen, bedingt durch Humanendrogen. | |
JP2716461B2 (ja) | プロゲステロン合成阻害剤及び抗ゲスタゲンを含有する医薬及びその製法 | |
CA2163878A1 (en) | Agents containing a compound with an anti-androgen effect and a compound with a competitive, progesterone-antagonistic effect | |
IE53394B1 (en) | An aromatase-inhibitor together with an anti-androgen for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia,and pharmaceutical preparations and packs suitable for such a use | |
EP1522306A1 (de) | Ein pharmazeutisches Produkt zur Hormonersatztherapie enthaltend Tibolon oder eines seiner Derivate und Oestradiol oder eines seiner Derivate | |
IE84077B1 (en) | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8104624-5 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8104624-5 Format of ref document f/p: F |